Market Entry Sprint
Six to ten weeks. Regulatory marketing audit, US-facing compliance and trust architecture rebuild, RFP-response template update for one US category and corridor.
See the Sprint →
For Mittelstand engineering firms whose marketing materials still reference EU compliance markers as primary credibility signals when targeting US OEMs and US enterprise buyers. The legal regimes do not overlap and the marketing claim has to be rebuilt to reflect that.
The German compliance line is not wrong. It is not the line a US enterprise buyer reads.
The European and United States regulatory frameworks are non-overlapping for most engineering categories. CE marking is a self-declaration of conformity to EU directives and is not recognised by US federal regulators. FDA 510(k) and de novo clearance for medical devices are independent of CE and MDR; a Class II device cleared in the EU still requires a 510(k) submission to enter US market. The Pre-Sub meeting before a 510(k) submission saves substantial time and is rarely on the German team's radar in the first US planning cycle.
FCC certification for radio and electronic equipment is a separate filing from CE for radio equipment. NRTL listing (UL, ETL, CSA) is required at most US worksites and is not satisfied by CE compliance. ISO 13485 partially aligned with FDA QSR through the QMSR transition that began in February 2026, but the alignment is partial, not retroactive, and does not eliminate the 510(k) requirement.
On the data and privacy side, GDPR has no US federal equivalent. The United States operates a state-level patchwork of consumer-privacy laws (California CCPA and CPRA, Virginia VCDPA, Colorado CPA, Connecticut, Utah, Texas, and others) with materially different definitions, opt-out rights, and enforcement. A GDPR-translated privacy notice neither satisfies the state-level requirements nor reads as a US-buyer-facing privacy posture.
On the federal procurement and defense-adjacent side, US gates are explicit and enumerated. SAM.gov UEI replaced DUNS. CAGE code registration is required. NIST 800-171 self-attestation and CMMC are required for handling Controlled Unclassified Information. ITAR registration is required for defense articles. None of these have European equivalents, and a German firm operating from CE-only credentials does not appear on the buyer's qualified-supplier list at all.
This is not a complaint about either regime. It is a description of why the same product, with the same engineering, requires a different regulatory marketing posture in the United States than in Europe. The firm needs counsel and regulatory specialists to build the legal layer alongside the marketing rebuild.
US enterprise and OEM procurement cycles delay by quarters while the firm scrambles to assemble US-side documentation under deal pressure. The accounts the firm intended to win in year one slide to year two or beyond, and competitors with US-built regulatory posture take the slot.
US insurance and warranty exposure is mispriced into the firm's cost model. When the actual underwriting comes back, US deals that looked accretive at the modeled premium are at-or-below margin at the actual premium. The firm either accepts thinner US margin or walks from accounts that would have been viable with the right posture from day one.
US federal, defense-adjacent, and government-affiliated procurement is structurally inaccessible without SAM.gov UEI, CAGE, NIST self-attestation, and the relevant export classifications. The firm's addressable US market is materially smaller than headquarters' assumption, until the gates are passed.
US privacy and data-handling exposure becomes a state-by-state risk that the German team monitors from headquarters and underestimates. The first US privacy claim, even nuisance-level, costs more in legal fees and reputational damage than rebuilding the privacy posture would have cost prospectively.
The firm's German marketing manager interprets US regulatory friction as bureaucratic, complains about it internally, and develops an internal narrative that the US market is "harder than it should be." The narrative makes the eventual rebuild harder because internal commitment to it is lower.
Six to ten weeks. Regulatory marketing audit, US-facing compliance and trust architecture rebuild, RFP-response template update for one US category and corridor.
See the Sprint →Three to six months. Full multi-channel US-facing regulatory posture rebuild. Site, supplier-qualification packet, partner channel enablement, sales-team briefing, OEM-facing dossier.
See the Build →Monthly retainer, twelve-month minimum. Ongoing regulatory marketing management for groups with multiple US-facing engineering brands across overlapping regulatory regimes.
See the Partnership →No legal services. No regulatory filings. No FDA 510(k), de novo, or Pre-Sub submissions. No FCC, NRTL, UL, ETL, or CSA listing applications. No NIST 800-171 or CMMC assessments. No SAM.gov UEI or CAGE registration. No ITAR or EAR classification. No US privacy compliance work. No product liability counsel. No insurance brokerage. No US contract drafting. No IP filing.
The firm runs the marketing and positioning layer. Regulatory affairs, US counsel, privacy counsel, US insurance brokers, and certification-body queues run the filings and the legal compliance. Where the firm flags a regulatory gate, the firm names it and routes to the relevant specialist before any marketing claim is published.
Mostly yes for engineering categories. CE marking does not satisfy FDA 510(k) for medical devices. CE for radio equipment does not satisfy FCC for the United States. CE for industrial equipment does not satisfy NRTL listing requirements at US worksites. ISO 13485 partially aligns with FDA QSR through the QMSR transition that began in February 2026, but the alignment is partial and not portable to all device classes. The marketing claim has to reflect this. A homepage claiming compliance using EU acronyms reads as foreign and uncovered to a US procurement officer.
GDPR is the EU regime. The United States has a state-level patchwork: California's CCPA and CPRA, Virginia's VCDPA, Colorado's CPA, Connecticut, Utah, Texas, and others, each with different definitions and consumer rights. A privacy notice translated from a German GDPR notice neither satisfies state-level US requirements nor reads as a US-buyer-facing privacy posture. The marketing surface and the legal compliance both need US-side rebuilding, with privacy counsel running the legal layer.
US tort liability is a separate framework. Product liability insurance premiums for foreign manufacturers entering the US are typically two-to-four times the European equivalent, and the underwriting requires US-specific documentation: warning labels in US English, US-facing user manuals, US-state-specific warranty disclaimers, and US-side responsible-person designations. The marketing materials reference these in places they do not exist in European materials.
The marketing work covers how the firm represents its US regulatory posture on the website, in the deck, on the RFP-response template, and in trade-show materials. The regulatory work itself, FDA filings, FCC certification, NRTL listing, US privacy compliance, US tort and insurance posture, is the work of regulatory consultants and US counsel. The firm runs the marketing and routes everything else.
With an inquiry and a short discovery conversation. Send the current US-facing pages that reference compliance, the RFP-response template, and the strategic US accounts and OEMs the firm needs to qualify with. Response within one business day.
The pillar piece on rebuilding US regulatory and commercial posture for medtech and biotech firms entering the United States.
Read the pillar →The dedicated lead profile for industrial-IoT and connected-machinery firms reconciling EU compliance with US enterprise procurement gates.
See the lead profile →The sibling pain page on US procurement scaffolding where regulatory gates are scored alongside commercial and engineering capability.
See the pain →